Association between cystatin C and major adverse cardiac events in patients with ischemic heart disease and type 2 diabetes mellitus after acute coronary syndrome
Purpose. To evaluate the level of cystatin C and its association with the risk of developing repeated major adverse cardiac events (MACE) in patients with ischemic heart disease (IHD) and preserved kidney function in combination with type 2 diabetes mellitus (DM) within 12 months after acute coronar...
Saved in:
| Main Authors: | S. A. Serik, T. H. Ovrakh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2019-06-01
|
| Series: | Zaporožskij Medicinskij Žurnal |
| Subjects: | |
| Online Access: | http://zmj.zsmu.edu.ua/article/view/168962/169282 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cystatine C role in predicting the in-hospital adverse outcomes of coronary artery bypass graft surgery
by: K. S. Shafranskaya, et al.
Published: (2013-06-01) -
The role of cystatin C in kidney injury in children and adolescents with type 1 diabetes mellitus: a systematic review
by: Nikolaos Gkiourtzis, et al.
Published: (2025-08-01) -
Association of Difference Between eGFR From Cystatin C and Creatinine and Serum GDF‐15 With Adverse Outcomes in Diabetes Mellitus
by: Tomohito Gohda, et al.
Published: (2025-08-01) -
The Predictive Power of the Cystatin C‐Creatinine Score in Assessing Frailty
by: Li Deng, et al.
Published: (2025-01-01) -
Serum cystatin C as a marker of glomerular kidney damage in patients with chronic glomerulonephritis with saved renal function
by: O. V. Kraydashenko, et al.
Published: (2015-06-01)